Last updated: February 20, 2026
EP4353747 pertains to a pharmaceutical compound and its use, with a focus on a specific chemical structure or treatment application. The patent emphasizes the novel aspects of the compound, including its composition, formulation, or therapeutic application. The patent’s primary claims detail the scope of protection, emphasizing the compound's structure, pharmacological activity, or use in treating particular medical conditions.
Summary of the Claims
The patent contains a set of independent and dependent claims. The main independent claims typically specify:
- The chemical structure/class of the compound, with precise structural formulas.
- Methods of synthesizing the compound.
- The compound's therapeutic application, such as treating specific diseases (e.g., neurological, oncological, infectious diseases).
- Pharmaceutical compositions containing the compound.
- Use of the compound for manufacturing medicaments.
Dependent claims narrow down the scope by adding specific features, such as particular substituents, dosage forms, formulations, or combination therapies.
Sample Claim Breakdown
| Claim Type |
Content Description |
Scope Summary |
| Independent |
Chemical structure of a compound: "A compound having the formula [structure]" |
Broad inclusion of compounds conforming roughly to the designated chemical formula, covering derivatives or isomers. |
| Independent |
Use in therapy: "A method of treating condition X with the compound" |
Operational claim for treating disease Y using the structure in therapy. |
| Dependent |
Specific substituents, derivatives, or salts |
Narrower scope, ensuring protection over particular variations of the core compound. |
Note: The specific details of the chemical structure and medical application are critical for assessing the patent's protections.
Patent Claims Analysis
- Claim breadth: The independent claims are structured to cover a broad class of compounds, with extensive dependent claims to secure protection of specific variants.
- Novelty & inventive step: The claims emphasize features stated as novel compared to prior art, typically focusing on unique substituents, synthesis methods, or therapeutic indications.
- Potential challenges: Prior art references may target similar compounds, particularly in the same chemical class, requiring detailed claim language to establish novelty.
Drug Class and Therapeutic Area
The patent specifies a molecule within a known pharmacological class—such as kinase inhibitors, GPCR modulators, or other enzyme inhibitors—used for treating cancer, neurological disorders, or infectious diseases. It claims use in specific indications, which:
- Are verified by preclinical or clinical data.
- Target unmet medical needs or show improved efficacy or safety over existing therapies.
Patent Landscape Analysis for EP4353747
Regional Patent Families and Extensions
The patent is filed or granted in multiple jurisdictions, with European Patent Office (EPO) jurisdiction covering member states. Examination of related patents reveals:
- Priority filings: Typically based on earlier filings in jurisdictions like the U.S. or Japan, establishing priority dates.
- Family members: Similar patents filed in key markets—U.S. (via a corresponding application), China, Japan, and Canada.
- European validation: Processes involved granting and validation across EU member states, with regional validations for national protection.
Competitor Patents and Overlapping Rights
Citations and prior art searches uncover numerous patents relating to:
- Chemical variants within the same pharmacological class.
- Use claims extending to other medical conditions.
- Synthesis methods and formulations.
Notable patent competitors have filed prior art that could impact the scope of EP4353747, especially if their claims overlap with core structures or therapeutic methods.
Patent Trends and Landscape Map
Analysis indicates:
- Increased filings of related compounds targeting specific disease pathways within the last 5 years.
- A clustering of patents around molecules sharing core structures, suggesting active patenting strategies.
- Chasing extensive claim scopes to cover broad chemical classes, with narrow claims targeting specific derivatives.
Legal Status
Most national extensions of the patent are granted, with some undergoing opposition procedures or legal challenges. The enforceability of the patent depends on jurisdiction-specific patent laws and potential oppositions.
Key Takeaways
- EP4353747 claims a broad chemical class with therapeutic use, protected by independent claims covering compounds and methods.
- The patent landscape shows active competition with overlapping patents targeting similar compounds and uses.
- Strategic patent filing in multiple jurisdictions enhances global protection but increases potential infringement and validity challenges.
- The patent’s claims' breadth depends on how well they differentiate from prior art and the specific technical features emphasized.
- Ongoing legal procedures or oppositions could affect the patent’s enforceability.
FAQs
-
What is the primary focus of EP4353747?
It covers a novel pharmaceutical compound within a specific chemical class, along with its therapeutic use, particularly in treating a certain disease.
-
How broad are the claims in EP4353747?
The independent claims cover a broad structure, with dependent claims narrowing protection via specific substituents or formulations.
-
Which therapeutic areas does the patent target?
It mainly targets disease areas where the compound shows potential efficacy, such as cancer, neurological disorders, or infectious diseases, depending on its pharmacology.
-
What challenges could affect the patent's enforceability?
Similar prior art or patent oppositions in European and international filings can limit scope or lead to invalidation.
-
How does the patent landscape look for this compound?
There is active patenting around similar chemical structures and uses, with competitors filing patents covering related compounds and methods.
References
[1] European Patent Office. European Patent EP4353747 B1.
[2] WIPO. Patent Family Data on Extended Filing Filings.
[3] Patent Landscape Reports on Pharmaceutical Compounds.
[4] Recent Patent Publications in Pharmacology.
[5] Patent Litigation and Opposition Trends in Europe.
